BIOLASE (NASDAQ:BIOL) Receiving Somewhat Favorable Press Coverage, Analysis Shows

Headlines about BIOLASE (NASDAQ:BIOL) have been trending somewhat positive on Sunday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. BIOLASE earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news headlines about the medical technology company an impact score of 43.8972878670746 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

BIOLASE (NASDAQ BIOL) traded down $0.01 during midday trading on Friday, hitting $0.42. 75,965 shares of the stock traded hands, compared to its average volume of 109,258. BIOLASE has a 12-month low of $0.28 and a 12-month high of $1.54.

In other BIOLASE news, major shareholder Larry N. Feinberg purchased 12,545,615 shares of BIOLASE stock in a transaction dated Tuesday, December 5th. The stock was purchased at an average price of $0.43 per share, with a total value of $5,394,614.45. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 7.10% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This report was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at

BIOLASE Company Profile

BIOLASE, Inc (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers.

Insider Buying and Selling by Quarter for BIOLASE (NASDAQ:BIOL)

Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with's FREE daily email newsletter.

Leave a Reply